Cardiovascular Department, Azienda Sanitaria Universitaria Giuliano Isontina, University of Trieste, Trieste, Italy.
J Cardiovasc Med (Hagerstown). 2021 Aug 1;22(8):626-630. doi: 10.2459/JCM.0000000000001182.
To evaluate the prevalence and predictors of persistent sinus rhythm in a recent cohort of unselected patients undergoing electrical cardioversion for atrial fibrillation.
We enrolled all consecutive patients undergoing elective electrical cardioversion for atrial fibrillation between January 2017 and December 2018. We analysed baseline clinical and echocardiographic data as well as pharmacological antiarrhythmic therapy. Primary endpoint was the maintenance of sinus rhythm at 12 months after electrical cardioversion.
Of the 300 patients enrolled, 270 (90%) had successful electrical cardioversion and among them, 201 patients have 12-month follow-up data (mean age 70 ± 10 years; 74% men). At 12 months, only 45.7% were in sinus rhythm. Patients without sinus rhythm compared with persistent sinus rhythm at 12 months had a lower baseline left ventricle ejection fraction (LVEF) (49.1 ± 16 vs. 59.7 ± 9%, P = 0.02) and had more frequently a history of atrial fibrillation more than 12 months (55 vs. 34% P = 0.003). At the multivariate analysis, only the duration of the disease beyond 12 months (OR 0.26, 95% CI: 0.08-0.88, P = 0.032), LVEF (OR 1.06, 95% CI: 1.01-1.12, P = 0.012) and the presence of sinus rhythm at 1-month follow-up (OR 18.28, 95% CI: 3.3-100, P = 0.001) were associated with the probability of maintaining sinus rhythm at 12 months.
In unselected patients with atrial fibrillation undergoing elective electrical cardioversion, only 45.7% were in sinus rhythm at 12 months. The presence of sinus rhythm at 1-month follow-up emerged as an independent predictor of maintenance of sinus rhythm. This highlights that early re-evaluation of these patients appears useful for assessing longer term outcomes also from the perspective of a possible selective approach to ablation strategies.
评估最近一组未经选择的接受电复律治疗心房颤动患者中持续性窦性心律的发生率和预测因素。
我们纳入了 2017 年 1 月至 2018 年 12 月期间所有接受择期电复律的心房颤动连续患者。我们分析了基线临床和超声心动图数据以及药物抗心律失常治疗。主要终点是电复律后 12 个月时维持窦性心律。
在 300 名入组患者中,270 名(90%)患者电复律成功,其中 201 名患者有 12 个月随访数据(平均年龄 70±10 岁,74%为男性)。在 12 个月时,仅有 45.7%的患者处于窦性心律。与 12 个月时持续窦性心律相比,无窦性心律的患者左心室射血分数(LVEF)基线值较低(49.1±16%比 59.7±9%,P=0.02),且更常患有 12 个月以上的心房颤动病史(55%比 34%,P=0.003)。多变量分析显示,只有疾病持续时间超过 12 个月(OR 0.26,95%CI:0.08-0.88,P=0.032)、LVEF(OR 1.06,95%CI:1.01-1.12,P=0.012)和 1 个月随访时存在窦性心律(OR 18.28,95%CI:3.3-100,P=0.001)与 12 个月时维持窦性心律的概率相关。
在接受择期电复律的未经选择的心房颤动患者中,仅有 45.7%的患者在 12 个月时处于窦性心律。1 个月随访时存在窦性心律是维持窦性心律的独立预测因素。这表明,早期重新评估这些患者似乎有助于评估更长时间的结果,也可以从可能的消融策略选择性方法的角度进行评估。